Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Profiles of GH Using Two Different Administration Regimes
NCT01090778Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2010
- Primary completion
- Dec 2011
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of Norditropine SimpleXx in growth hormone deficiency (GHD), sponsored by Aarhus University Hospital. Started Oct 2010; status: completed.
02
Drugs
Norditropine SimpleXx
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01090778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090778.